Thursday, May 11, 2017

Oncogene - Table of Contents alert Volume 36 Issue 19

If you are unable to see the message below, click here to view.
Oncogene

Advertisement
Springer Nature offers a free open access funding support service to enable authors to discover and apply for article processing charge funding available to them.

Visit our website for further advice on the funding options available, and guidance in approaching funders and institutions, or email openaccess@nature.com for more information.

TABLE OF CONTENTS

Volume 36, Issue 19 (May 2017)

In this issue
Reviews
Original Articles

Also new
AOP
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe

Reviews

Top

Non-metabolic functions of glycolytic enzymes in tumorigenesis

X Yu and S Li

Oncogene 2017 36: 2629-2636; advance online publication, October 31, 2016; 10.1038/onc.2016.410

Abstract | Full Text

Cancer heterogeneity is not compatible with one unique cancer cell metabolic map OPEN

A Strickaert, M Saiselet, G Dom, X De Deken, J E Dumont, O Feron, P Sonveaux and C Maenhaut

Oncogene 2017 36: 2637-2642; advance online publication, October 31, 2016; 10.1038/onc.2016.411

Abstract | Full Text

Original Articles

Top

FOXO3 is essential for CD44 expression in pancreatic cancer cells

M Kumazoe, M Takai, J Bae, S Hiroi, Y Huang, K Takamatsu, Y Won, M Yamashita, S Hidaka, S Yamashita, S Yamada, M Murata, S Tsukamoto and H Tachibana

Oncogene 2017 36: 2643-2654; advance online publication, November 28, 2016; 10.1038/onc.2016.426

Abstract | Full Text

The LIM protein AJUBA promotes colorectal cancer cell survival through suppression of JAK1/STAT1/IFIT2 network

H Jia, L Song, Q Cong, J Wang, H Xu, Y Chu, Q Li, Y Zhang, X Zou, C Zhang, Y E Chin, X Zhang, Z Li, K Zhu, B Wang, H Peng and Z Hou

Oncogene 2017 36: 2655-2666; advance online publication, November 28, 2016; 10.1038/onc.2016.418

Abstract | Full Text

MicroRNA-383 located in frequently deleted chromosomal locus 8p22 regulates CD44 in prostate cancer

N Bucay, K Sekhon, T Yang, S Majid, V Shahryari, C Hsieh, Y Mitsui, G Deng, Z L Tabatabai, S Yamamura, G A Calin, R Dahiya, Y Tanaka and S Saini

Oncogene 2017 36: 2667-2679; advance online publication, November 28, 2016; 10.1038/onc.2016.419

Abstract | Full Text

Blood vessel endothelium-directed tumor cell streaming in breast tumors requires the HGF/C-Met signaling pathway OPEN

E Leung, A Xue, Y Wang, P Rougerie, V P Sharma, R Eddy, D Cox and J Condeelis

Oncogene 2017 36: 2680-2692; advance online publication, November 28, 2016; 10.1038/onc.2016.421

Abstract | Full Text

Hic-5 remodeling of the stromal matrix promotes breast tumor progression

G J Goreczny, J L Ouderkirk-Pecone, E C Olson, M Krendel and C E Turner

Oncogene 2017 36: 2693-2703; advance online publication, November 28, 2016; 10.1038/onc.2016.422

Abstract | Full Text

Caspase-2-mediated cell death is required for deleting aneuploid cells OPEN

S Dawar, Y Lim, J Puccini, M White, P Thomas, L Bouchier-Hayes, D R Green, L Dorstyn and S Kumar

Oncogene 2017 36: 2704-2714; advance online publication, December 19, 2016; 10.1038/onc.2016.423

Abstract | Full Text

TGF-β upregulates the translation of USP15 via the PI3K/AKT pathway to promote p53 stability OPEN

W-T Liu, K-Y Huang, M-C Lu, H-L Huang, C-Y Chen, Y-L Cheng, H-C Yu, S-Q Liu, N-S Lai and H-B Huang

Oncogene 2017 36: 2715-2723; advance online publication, November 28, 2016; 10.1038/onc.2016.424

Abstract | Full Text

SIRT4 inhibits malignancy progression of NSCLCs, through mitochondrial dynamics mediated by the ERK-Drp1 pathway

L Fu, Q Dong, J He, X Wang, J Xing, E Wang, X Qiu and Q Li

Oncogene 2017 36: 2724-2736; advance online publication, December 12, 2016; 10.1038/onc.2016.425

Abstract | Full Text

Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition OPEN

F Mateo, E J Arenas, H Aguilar, J Serra-Musach, G Ruiz de Garibay, J Boni, M Maicas, S Du, F Iorio, C Herranz-Ors, A Islam, X Prado, A Llorente, A Petit, A Vidal, I Català, T Soler, G Venturas, A Rojo-Sebastian, H Serra, D Cuadras, I Blanco, J Lozano, F Canals, A M Sieuwerts, V de Weerd, M P Look, S Puertas, N García, A S Perkins, N Bonifaci, M Skowron, L Gómez-Baldó, V Hernández, A Martínez-Aranda, M Martínez-Iniesta, X Serrat, J Cerón, J Brunet, M P Barretina, M Gil, C Falo, A Fernández, I Morilla, S Pernas, M J Plà, X Andreu, M A Seguí, R Ballester, E Castellà, M Nellist, S Morales, J Valls, A Velasco, X Matias-Guiu, A Figueras, J V Sánchez-Mut, M Sánchez-Céspedes, A Cordero, J Gómez-Miragaya, L Palomero, A Gómez, T F Gajewski, E E W Cohen, M Jesiotr, L Bodnar, M Quintela-Fandino, N López-Bigas, R Valdés-Mas, X S Puente, F Viñals, O Casanovas, M Graupera, J Hernández-Losa, S Ramón y Cajal, L García-Alonso, J Saez-Rodriguez, M Esteller, A Sierra, N Martín-Martín, A Matheu, A Carracedo, E González-Suárez, M Nanjundan, J Cortés, C Lázaro, M D Odero, J W M Martens, G Moreno-Bueno, M H Barcellos-Hoff, A Villanueva, R R Gomis and M A Pujana

Oncogene 2017 36: 2737-2749; advance online publication, December 19, 2016; 10.1038/onc.2016.427

Abstract | Full Text

Different in vivo and in vitro transformation of intestinal stem cells in mismatch repair deficiency

K Keysselt, T Kreutzmann, K Rother, C Kerner, K Krohn, J Przybilla, P Buske, H Löffler-Wirth, M Loeffler, J Galle and G Aust

Oncogene 2017 36: 2750-2761; advance online publication, December 12, 2016; 10.1038/onc.2016.429

Abstract | Full Text

Oxidative stress downstream of mTORC1 but not AKT causes a proliferative defect in cancer cells resistant to PI3K inhibition OPEN

M Dermit, P Casado, V Rajeeve, E H Wilkes, D E Foxler, H Campbell, S Critchlow, T V Sharp, J G Gribben, R Unwin and P R Cutillas

Oncogene 2017 36: 2762-2774; advance online publication, December 19, 2016; 10.1038/onc.2016.435

Abstract | Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature
 

No comments: